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ABSTRACT: Environmental risk assessment of pharmaceut-
icals requires the determination of their environmental
exposure concentrations. Existing exposure modeling ap-
proaches are often computationally demanding, require
extensive data collection and processing eﬀorts, have a limited
spatial resolution, and have undergone limited evaluation
against monitoring data. Here, we present ePiE (exposure to
Pharmaceuticals in the Environment), a spatially explicit
model calculating concentrations of active pharmaceutical
ingredients (APIs) in surface waters across Europe at ∼1 km
resolution. ePiE strikes a balance between generating data on
exposure at high spatial resolution while having limited
computational and data requirements. Comparison of model
predictions with measured concentrations of a diverse set of
35 APIs in the river Ouse (UK) and Rhine basins (North West Europe), showed around 95% were within an order of
magnitude. Improved predictions were obtained for the river Ouse basin (95% within a factor of 6; 55% within a factor of 2),
where reliable consumption data were available and the monitoring study design was coherent with the model outputs.
Application of ePiE in a prioritisation exercise for the Ouse basin identiﬁed metformin, gabapentin, and acetaminophen as
priority when based on predicted exposure concentrations. After incorporation of toxic potency, this changed to desvenlafaxine,
loratadine, and hydrocodone.
■ INTRODUCTION
Over the past decades, human consumption of pharmaceuticals
has steadily increased.1,2 In combination with continuing
improvements in our analytical capabilities,3,4 this has led to
the detection of many active pharmaceutical ingredients
(APIs) in surface waters worldwide.5,6 The environmental
presence of 631 diﬀerent pharmaceuticals has been reported in
71 countries covering all continents,5 but the actual number of
APIs present in surface waters is likely higher due to the self-
fulﬁlling selection bias of many monitoring campaigns.7
A crucial step in the environmental risk assessment of
chemicals is the determination of their environmental exposure
potential. Since there are currently at least 1500 distinct APIs
in use,8,9 monitoring all of them everywhere and continuously
is practically impossible. Moreover, APIs under development
will not be present in the environment so monitoring will
provide no information on exposure of these molecules. There
is therefore a need for exposure modeling approaches that can
help us prioritize our monitoring eﬀorts, support more robust
environmental risk assessment of new APIs, and that can be
used to take targeted measures.10 These should preferably be
spatially explicit, acknowledging that geographical variability
can lead to substantial diﬀerences in the concentrations of
APIs across and within regions.11,12 For example, rankings of
APIs established at the continental European level may lead to
misguided allocation of resources when adopted at a regional
level.12 Such mismatches between EU-level and regional level
prioritization of APIs might, for example, be the result of
geographical variation in API consumption, a heterogeneous
distribution of emission sources, or spatially varying environ-
mental conditions driving the fate of APIs after emission.
The environmental exposure potential of chemicals is
reﬂected by the measured (MEC) or predicted (PEC)
environmental concentrations at which they occur in the
environmental compartment of interest. PECs can be derived
using multimedia fate models, such as the EUSES model13 and
our previously developed prioritization tool for APIs.11 These
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are based on mass-balance equations for interconnected
compartments that represent the relevant environmental
media (e.g., fresh and salt waters, air, urban and agricultural
soils, et cetera), and are therefore especially useful for larger
scale (regional, continental) assessments where multiple media
might be relevant. However, they are less suitable for
answering locally speciﬁc questions (e.g., hotspot identiﬁca-
tion, scenario analyses for optimal mitigation measures),
because they assume a homogeneous distribution of chemicals
within their compartments and do not account for any spatial
variation at that scale.14,15 This also inherently limits the
options for model corroboration with local measurement data.
APIs tend to largely remain in the compartment where they
are emitted,16 implying that the use of single-media models is
also an option. Examples of geographically based single-media
models for down-the-drain chemicals are GREAT-ER,17
PhATE,18 GWAVA,19 LF2000-WQX,20 iSTREEM,21 and the
recent unnamed model by Grill et al.15 Combined, these
models have been applied to assess the distribution of APIs in
many river basins worldwide. Invariably, they integrate
information on API consumption, human metabolism, removal
in wastewater treatment plants (WWTPs), and dilution and
dissipation in receiving surface waters, to estimate PECs
throughout river basins. The characterization of hydrology is
broadly done in one of two ways: via gridded approaches
incorporating extensive process-based hydrological models,15,19
or via segmentation of the river network into discrete river
segments with calibration against measured hydrology and
extrapolation to ungauged sites.17,18,20,21 Both approaches have
their own drawbacks, related to the computational demands of
large scale hydrological models, the extensive data collection
and processing eﬀorts required for the parametrization of river
basins, and the limited spatial resolution determined by the
grid-cell size or the length of individual river segments.
Here, we present ePiE (exposure to Pharmaceuticals in the
Environment), a new spatially explicit model, developed in the
frame of the Innovative Medicines Initiative iPiE project, that
can calculate concentrations of APIs in surface waters
throughout river basins in Europe. It is designed to strike a
balance between generating data on exposure at high spatial
resolution while having limited computational and data
requirements. It does so by employing FLO1K for the
underlying hydrology, a global geographic data set with annual
predictions of streamﬂow metrics (annual mean ﬂow, highest
and lowest monthly mean ﬂow) spatially distributed at 30 arc
seconds (∼1 km).22 This is a resolution 10 times higher than
the most detailed global hydrological models or land surface
models currently available.23,24 In ePiE, river networks are
represented as collections of interconnected nodes describing
emission points, river junctions, river mouths and inlets and
outlets of lakes and reservoirs. It thus provides a modeling
architecture supporting linkage and integration of geographic
information in vector format, i.e., the nodes of the river
networks, and rasterized information on climatic, hydrological,
and geochemical conditions.25 We developed a custom routing
scheme to follow APIs through the river network, along the
way accounting for dissipation from the water via the processes
of biodegradation, photolysis, hydrolysis, volatilization and
sedimentation.
In this article, we present the structure of ePiE and evaluate
its performance against measured concentration data from the
open literature for a combined total of 35 APIs in two
European river basins. Finally, to illustrate the utility of the
model, we apply ePiE to rank APIs in the river Ouse basin
(UK), based on predicted concentrations in surface waters and
predicted risks to ﬁsh.
■ MATERIALS AND METHODS
Model Structure. Central to ePiE are a set of network
nodes derived from the global databases HydroSHEDS26 and
HydroLAKES,27 and agglomerations and WWTPs from the
UWWTD-Waterbase.28 This latter database contains informa-
tion on the location and characteristics (i.e., generated load,
design capacity and level of treatment) of 30 043 European
urban WWTPs and 27 695 agglomerations with generated
wastewater loads above 2000 population equivalents (p.e.).
After curation of the UWWTD-Waterbase (see Supporting
Information (SI) S1), agglomerations and WWTPs were
incorporated into the river network based on their proximity to
the nearest water body. Direct emissions into the sea were
excluded from the model. Finally, gridded information on air
temperature, wind speed, slope, and streamﬂow was extracted
to all nodes in the network. To optimize its ﬂexibility and
accessibility, ePiE is entirely constructed in the open-source
software environment R,29 and a description of the model
construction can be found in SI S2.
The ePiE model has a modular structure based on the
georeferenced river basins provided by the global Hydro-
BASINS database25 which includes basins below of 60°N.
Depending on the river basin of interest, a subset of the total
network of nodes is geographically selected. As a starting point,
ePiE then requires yearly consumption data for the API of
interest (kg/year) for all countries the river basin covers. When
the API of interest is formed as a metabolite from another API,
that is, its prodrug, consumption data for that prodrug are also
needed. Yearly emissions into the river network from WWTPs
(Ew,wwtp; kg/year) and from agglomerations with incomplete
WWTP connectivity (Ew,agg; kg/year) are calculated via eq 1
and eq 2, respectively. The country-speciﬁc yearly con-
sumption data (M) include the prescription of pharmaceuticals
in hospitals. This means that hospital emissions are not
included as location-speciﬁc point sources, but spatially
distributed according to the wastewater loads per agglomer-
ation (i.e., a proxy for population density).
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where M and Mpd are the yearly consumption of the API of
interest and its prodrug in the relevant country (kg/year); f pc is
the fraction of the administered parent compound excreted/
egested unchanged or as reversible conjugates via urine and
faeces (−); fmet is the fraction of prodrug metabolized to the
API of interest, and subsequently excreted/egested via urine
and faeces (−); n is the number of agglomerations j connected
to the WWTP (−); fconn,agg,j is the level of WWTP connectivity
per agglomeration j; fwwtp,agg,j is the fraction of agglomeration j
connected to the WWTP; f rem is the API-speciﬁc removal
eﬃciency per WWTP (−); and Vww,agg,j and Vww,cnt are the
wastewater loads generated per agglomeration j and the total in
the relevant country, respectively (p.e.).
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The SimpleTreat 4.0 model30,31 was incorporated into ePiE
to estimate the removal eﬃciency during wastewater treatment
( f rem). It requires basic physicochemical properties as input, as
well as solids-water partitioning coeﬃcients for primary sewage
(Kpps; L/kg) and activated sludge (Kpas; L/kg), and (pseudo)-
ﬁrst order biodegradation rate constants (kbio,wwtp; s
−1).
Removal eﬃciencies were assigned to individual WWTPs
depending on their associated level of treatment, using either
the full SimpleTreat 4.0 model for those employing
consecutive primary and secondary treatment, or the module
for primary treatment only.
After their emission, API residues are followed through the
river network using a routing procedure ordered from the most
upstream to the most downstream nodes. As such, the
contribution of all upstream emissions to local concentrations
is considered. Along the way, ePiE accounts for dilution in the
water column and ﬁve (pseudo)ﬁrst order loss processes, three
being degradation processes, that is, biodegradation, photolysis
and hydrolysis, and two being intermedia transport processes,
that is, sedimentation and volatilization. Eq 3 calculates
concentration Ci (μg/L) at any node i in the river network;
eq 4 calculates concentrations in lakes and reservoirs, following
an approach similar to Grill et al.15 in which they are modeled
as single completely stirred tank reactors.
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where Ew,i and Ew,j are the emissions into the river network at
node i and at node j upstream from node i, respectively (mg/
s); n is the total number of nodes upstream from node i (−);
dj−i is the distance over the river network between node j and
node i (m); km,dj−i is the average (pseudo-) ﬁrst order rate
constant for loss process m over dj−i (s
−1); vdj−i is the average
river ﬂow velocity over dj−i (m/s); and Qi is the total river ﬂow
at node i (m3/s), including any discharges.
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where Ew,p is the emission into lake or reservoir i coming from
node p (mg/s), which can either be a direct emission source
(i.e., a WWTP or an agglomeration), or an inlet point carrying
API residues from upstream the river network; n is the total
number of nodes emitting into lake or reservoir i (−); HRTi is
the hydraulic retention time of lake or reservoir i (s); Vi is the
volume in lake or reservoir i (m3); and km,i is the (pseudo-)
ﬁrst order rate constant for loss process m in lake or reservoir i
(s−1).
Individual loss rate constants are extrapolated from test to
ﬁeld conditions by accounting for temperature diﬀerences,
sorption to suspended solids and dissolved organic carbon,32
and reduced light intensity.33 Local sedimentation and
volatilization rate constants are implemented via mass
transport velocities between media.34 Detailed information
on the extrapolation to ﬁeld conditions can be found in SI S3.
For characterization of annual mean ﬂow, and highest and
lowest monthly mean ﬂow, the recent global FLO1K data set
was implemented in ePiE.22 FLO1K is based on an ensemble
of artiﬁcial neural networks regressions, with upstream-
catchment physiography (area, slope, elevation) and year-
speciﬁc climatic variables (precipitation, temperature, potential
evapotranspiration, aridity index and seasonality indices) as
covariates. It provides estimations of ﬂow at a spatial resolution
of 30 arc seconds (∼1 km) for the years 1960−2015, which are
in good agreement with independent data (global R2 of single-
year metrics up to 0.91). An additional comparison with
independent data obtained from 1,007 European monitoring
stations for the period 2010−2015,35 showed that year-speciﬁc
annual mean ﬂow, and highest and lowest mean monthly ﬂow
in European rivers are predicted well, with R2 values of 0.97,
0.95, and 0.91, respectively (Figure 1).
Additional hydrological parameters ﬂow velocity vi (m/s)
and river depth hw,i (m), were calculated via the Manning’s
equation for open channel ﬂow, rewritten under the
assumption of a wide rectangular river cross section as
proposed by Pistocchi and Pennington.36 In this approach,
river width was related to river ﬂow using their power law
equation for European rivers (R2 of 0.87).36
Model Evaluation. We performed a model evaluation
exercise with measured concentrations for 35 APIs consumed
in Europe and covering a wide range of pharmaceutical classes.
Excretion, sorption and degradation data were extracted from
open literature by cross-referencing a set of reviews on human
metabolism, sludge sorption, sediment sorption, biodegrada-
tion and photolysis. The data obtained were supplemented
with additional API-speciﬁc searches. The resulting data set
was extensive, containing a total of 430 sorption coeﬃcients
and 342 degradation rate constants, but not homogeneously
distributed over the 35 APIs. Complete experimental data sets
were available for 13 APIs, while 12 were missing data on at
least one sorption process and 11 on at least one degradation
process. No experimental sorption or degradation data were
Figure 1. Validation results for year-speciﬁc annual mean ﬂow (A), highest monthly mean ﬂow (B) and lowest monthly mean ﬂow (C).
Independent validation data set consisted of yearly measurements (2010−2015) from 1,007 GRDC European stations. The solid line represents
perfect model ﬁt (1:1 line) and the dashed lines represent a diﬀerence of 1 order of magnitude.
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found for sitagliptin and triamterene. Missing sorption
coeﬃcients were substituted by combining default mass
fractions of organic carbon for sludge30 or sediments37 with
QSAR predictions of organic carbon−water partition coef-
ﬁcients.38,39 Moreover, if only ready biodegradability screening
test data were available, APIs were assigned a biodegradation
rate constant as proposed by Jager et al.40 When experimental
degradation rate constants were lacking altogether, no
degradation was assumed. SI Tables S4.1 and S4.2 show the
physicochemical and environmental fate properties of the 35
APIs, respectively.
Predicted environmental concentrations were compared
with measured concentrations extracted from a database
compiled by the German national environmental protection
agency,5 and a limited number of more recent literature
studies. Individual studies were included in the model
evaluation if (1) measurements were performed after 2010,
(2) measurement locations were provided, (3) at least 10 of
our APIs were measured above their limit of detection at least
10% of the time, and (4) multiple consecutive measurements
were performed over time. These criteria resulted in the
selection of three literature studies, being those by Burns et
al.,41 who measured APIs in the river Ouse basin in the United
Kingdom, and by Ruﬀ et al.42 and Munz et al.,43 who both
measured APIs in the river Rhine basin in Northwestern
Europe (Figure 2). Burns et al.41 included a total of 30 of our
preselected APIs in a monthly grab-sampling campaign
throughout 2016. They reported the coordinates of their 11
sampling locations, of which six were located along the river
Ouse and ﬁve along its tributary, the river Foss, and we
integrated these as such into ePiE. The yearly average of the
Burns et al.41 data set was compared to the PEC obtained
under annual mean ﬂow conditions for 2015. Ruﬀ et al.42
measured a total of 23 of our preselected APIs in a weekly
ﬂow-proportional composite sampling campaign during “a
remarkably dry period with constant low ﬂow conditions” in
the early spring of 2011. To reﬂect these low ﬂow conditions,
we used PECs derived under lowest monthly mean ﬂow for
2011 in the quantitative evaluation of model performance. Out
of their 16 sampling locations, ten were sampling stations along
the river Rhine, but their coordinates were not reported. We
georeferenced these sampling locations based on the proximity
of the cities mentioned by the authors to sampling stations in
the GRDC Station Catalogue.35 In addition, they sampled six
tributaries of the river Rhine. We assumed these were sampled
directly before their conﬂuence with the main river. Finally,
Munz et al.43 included a total of 11 of our preselected APIs in
two distinct grab-sampling campaigns in 2013 and 2014. Their
24 sampling locations were split evenly over these two
campaigns and were all located directly downstream of
WWTPs in Switzerland. Two sampling locations outside the
river Rhine basin were excluded from our model evaluation.
Similar to Ruﬀ et al.,42 Munz et al.43 explicitly chose their
sampling times to capture low ﬂow conditions. Therefore, we
used PECs derived under lowest monthly mean ﬂow
conditions for 2013 (site 1−12) and 2014 (site 13−24).
For estimations in the river Ouse basin, we used
consumption data for 2016 from the Prescription Cost
Analysis.44 For the river Rhine basin, consumption data for
The Netherlands were obtained from the Dutch National
Health Care Institute.45 German, French and Swiss con-
sumptions during the years of interest were mostly
Figure 2. Overview of studies included in the model evaluation exercise, with numbered sampling locations from Burns et al.41 (A), Ruﬀ et al.42
(B), and Munz et al.43 (C).
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extrapolated from per capita consumption in other years.46
Consumption data were not available for ﬁve APIs in France,
one API in Switzerland, and all APIs in Austria, Belgium, and
Luxembourg. In these cases, we averaged the per capita
consumption from the basin’s other countries. All consump-
tion data are presented in SI S5.
To assess the predictive accuracy of ePiE, we computed the
median symmetric accuracy ξ per study included in the
evaluation exercise (eq 5).47 This metric reﬂects the typical
percentage error of the predictions compared to the measure-
ments. For example, a ξ of 100% indicates that predicted
concentrations will typically be within a factor of 2 of the
measurements. Contrary to metrics based on scale-dependent
errors (e.g., root-mean-square error RMSE), ξ assigns equal
importance to deviations of the same order rather than the
same magnitude. This is especially relevant for our data where
concentrations ranged from low ng/L to μg/L levels. In other
words, a situation where the PEC is 1 ng/L and the MEC is 10
ng/L (absolute error 9 ng/L) receives an equal penalty to that
where the PEC is 100 ng/L and the MEC is 1 μg/L (absolute
error 900 ng/L). Moreover, since ξ bases on the median (M)
of the accuracy ratios of individual pairs of predictions and
measurements, it penalizes under- and overpredictions equally.
This is an advantage over the often-applied mean absolute
percentage error MAPE, which penalizes overpredictions more
heavily.47
e100 ( 1)M( ln(PEC /MEC ) )i iξ = · −[ | | ] (5)
Additionally, we assessed the prediction bias of ePiE by
computing the symmetric signed percentage bias (SSPB) (eq
6), which is closely related to the median symmetric accuracy
ξ.47 The SSPB can be interpreted similarly to a mean
percentage error, but is not aﬀected by the likely asymmetry
in the distribution of percentage error.
e
SSPB 100 sgn(M(ln(PEC /MEC )))
( 1)
i i
M(ln(PEC /MEC ))i i
= · ·
−[| |] (6)
Model Application. To illustrate the utility of the model,
we applied ePiE to prioritise APIs in the Ouse river basin, the
basin with the best model performance and most APIs
included. Additional nodes were integrated into the network at
evenly spaced one-kilometre distances, enabling a basin-wide
prioritisation using geographically homogeneous aggregate
statistics. In addition to a ranking based on concentrations,
we ranked the APIs based on their potential risks to ﬁsh. For
this we followed a similar method as Burns et al.,48 based on
the ﬁsh plasma model approach.49,50 We extrapolated
concentrations in surface water to concentrations in ﬁsh
plasma using bioconcentration factors computed according to
Fitzsimmons et al.51 for neutral compounds, and Fu et al.52 for
ionizing compounds. The latter were derived assuming a
surface water pH of 7.4.53 Risk quotients (RQ) for ﬁsh were
then calculated as the ratio of concentrations in ﬁsh plasma
over therapeutic concentrations in human plasma, which we
obtained from the MaPPFAST database.54 A risk quotient
exceeding 1 thus indicates that the concentration of an API in
surface water is expected to cause a pharmacological eﬀect in
ﬁsh, assuming equivalent pharmacological activity as in
humans.55 Finally, to enable exploration of local concentration
and risk patterns, model results were geographically visualized
as interactive html-maps, using the leaﬂet package “leaﬂetR” in
the R environment.56
■ RESULTS AND DISCUSSION
Out of the 940 predicted values used for model evaluation,
36% were qualiﬁed as nondetects in the measurement
campaign. We qualiﬁed a substance as a nondetect in case it
was below the limit of detection (LOD) in at least 40% of the
samples taken at that location. Such nondetects are less
suitable for a quantitative evaluation of model performance.
We did, however, include them in a binary comparison
between predicted min-max concentration ranges, resulting
from the temporal variation in ﬂow conditions, and measure-
ments in relation to their LOD (Figure 3). Assigning
comparisons to one of four bins (detected, predicted <
LOD; not detected, predicted > LOD; detected, predicted >
LOD; not detected, predicted < LOD), there was 94%, 88%,
and 90% coherence of predictions and measurements for the
Burns et al.,41 Ruﬀ et al.,42 and Munz et al.43 studies,
respectively (green bars in Figure 3).
For a quantitative assessment of model performance, we
included all detects at locations downstream of a WWTP, that
is, for which PEC > 0. In case measured values were below the
LOD (i.e., always less than 40%), these measurements were
replaced by 2 LOD
1
2
· .48 The resulting comparison of
predicted versus measured values (Figure 4) revealed a
substantial variation between the three studies. Model accuracy
was best for predictions in the Ouse river basin, with a typical
percentage error of 86% (Figure 4A; Burns et al.41).
Predictions in the river Rhine basin had typical percentage
errors of 143% (Figure 4B; Ruﬀ et al.42) and 158% (Figure 4C;
Munz et al.43). Model performance was similar if data points
were included for which PEC > LOD and for which more than
40% of the measurements were below the LOD (SI Figure
S6.1).
The worse performance of ePiE in the river Rhine basin
might relate to the quality of the consumption data used in the
calculations. First, Swiss and German consumption data were
often reported as “greater-than” values instead of exact
amounts.46 Second, we extrapolated the consumption in
2009 to that in the actual years of sampling (2011−2014),
based on changing demographics and the assumption of a
constant per capita consumption over the years (SI Table
S5.1). However, actual per capita consumption has increased
signiﬁcantly for at least some pharmaceuticals, e.g., anti-
diabetics like sitagliptin57 or antidepressants like venlafaxine.58
These were therefore underestimated by ePiE due to the
temporal extrapolation. In addition, errors might have been
introduced when sampling sites from Ruﬀ et al.42 were
allocated to the river network, because limited geographical
Figure 3. Binary comparison of measurements and min-max range of
predictions, relative to their limit of detection (LOD). All
combinations of location and API from Burns et al.41 (A), Ruﬀ et
al.42 (B), Munz et al.43 (C), and all studies combined (D).
Environmental Science & Technology Article
DOI: 10.1021/acs.est.8b03862
Environ. Sci. Technol. XXXX, XXX, XXX−XXX
E
detail was available on their speciﬁc locations. Inaccuracies
may also be due to the fact that HydroSHEDS does not
provide the real geometry of a river network in a basin, but
most likely ﬂow paths between individual cells according to
ﬂow accumulation. Similarly, errors might have been
introduced during the allocation to the river network of the
WWTPs sampled by Munz et al.43 These were all located at
smaller streams in the upper Swiss catchment of the Rhine
river basin, without other upstream emission sources. In such
smaller upstream catchments, proximity-based allocation is
more prone to errors because the main stream within the
ﬂoodplain is less easily identiﬁed. Nevertheless, the ξ values
and the scatterplots in Figure 4 indicate that concentrations
were typically predicted within a factor of 2−3, with
approximately 95% of predictions within a factor of 10.
Concentrations measured by Burns et al.41 were typically
underestimated by ePiE, with a symmetric signed percentage
bias (SSPB) of −44% (Figure 4A). From the scatterplot in
Figure 4A, underestimations seem to be more prominent at
lower concentrations. This can at least partly be explained by
the fact that measured concentrations have a lower bound in
the form of their LOD, while model predictions do not. As a
consequence, underestimations are more likely than over-
estimations in the vicinity of that LOD, since nondetects are
excluded from the comparison. Indeed, model performance
slightly improved if data points were included for which PEC >
LOD, and which had more than 40% of the measurements
below the LOD which were replaced by 2 LOD
1
2
· (SI Figure
S6.1). Additionally, the reliability of measured concentrations
decreases closer to the LOD. This complicates the evaluation
of model performance, because any diﬀerence between
predicted and measured concentrations might then be
attributed to errors in either of them. Finally, inputs from
tourism, speciﬁc point sources (e.g., hospitals), operation of
combined sewer overﬂows at selected times of the year and use
of over the counter medicines may also explain the slight
mismatch between measurements and predictions in the river
Ouse basin.
In contrast to the river Ouse basin, concentrations measured
in the river Rhine basin were typically slightly overestimated,
with SSPB values of 30% and 5% (Figures 4B and 4C). When
we ran ePiE under annual mean ﬂow settings, these values
dropped considerably to −70% and −313%, respectively. This
Figure 4. Predicted concentrations (i.e., > 0) versus detects (i.e., < 40% of the measurements below LOD), separately for data from Burns et al.41
(purple; A), Ruﬀ et al.42 (golden; B), Munz et al.43 (green; C), and for all studies combined (black; D). Concentrations predicted under annual
mean ﬂow conditions (A) or lowest monthly mean ﬂow conditions (B and C). Solid line represents 1:1 relationship; dashed lines represent 1:10
and 10:1 relationships. ξ: median symmetric accuracy; SSPB: symmetric signed percentage bias.
Figure 5. Ratios of predicted over measured concentrations (PEC/MEC), reported by Burns et al.,41 (A), Ruﬀ et al.,42 (B) and Munz et al.43 (C).
Colored dots are individual combinations of API and location, measured above the LOD; black bars represent 95th percentile and median over all
measurements per location (numbered as in Figure 2). Concentrations predicted under annual mean ﬂow conditions (A) or lowest monthly mean
ﬂow conditions (B and C). * = The PEC/MEC ratio of location 7 in panel A equals zero.
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Figure 6. Ranking of all APIs modeled with ePiE in the Ouse river basin, based on concentrations (A) and risk quotients for ﬁsh (B) predicted
throughout the river basin, excluding zero concentrations. Boxes indicate interquartile range including median; whiskers indicate 1st−99th
percentile range for the total river length. Red boxes: RQ exceeds 1 at least somewhere in the river network; amber boxes: RQ exceeds 0.1 at least
somewhere in the river network; green boxes: RQ below 0.1 throughout the river network.
Figure 7. Spatial distribution of risk quotients for the three top ranked APIs in the river Ouse basin (UK): desvenlafaxine (A), loratadine (B), and
hydrocodone (C). Panel D depicts the spatial variation in population density in the river Ouse basin (individuals/100 m2).
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indicates that actual streamﬂow during sampling was probably
somewhere between lowest monthly mean ﬂow and annual
mean ﬂow conditions.
Ratios of predicted over measured concentrations (PEC/
MEC ratios) provide further insights into the performance of
ePiE (Figure 5). PEC/MEC ratios are grouped according to
study and sampling location, numbered as in Figure 2. Similar
graphs grouped according to API are included in the
Supporting Information (SI Figure S6.2). Figure 5A shows
that the spread around predictions in the river Ouse (locations
1−6) is smaller than around those in its tributary river Foss
(locations 7−11). This indicates that ePiE predicts concen-
trations in larger rivers better than in smaller ones. While
concentrations in larger rivers reﬂect an accumulation of APIs
over a larger upstream catchment area, concentrations in
smaller rivers and streams are more directly inﬂuenced by
speciﬁc local conditions, that is, water extraction and retention
or small scale discharges. Indeed, comparison of predicted and
measured mean annual ﬂow at two gauging stations, i.e. one in
the river Ouse and one in the river Foss (SI Table S6.1), shows
that our ﬂow prediction is less accurate for the smaller river
Foss. The impact of local conditions can furthermore be
observed at the most upstream location on the river Foss
(location 7), where multiple APIs were detected but ePiE
predicted zero concentrations for all of them. This deviation
was likely due to the presence of a small upstream WWTP not
included in the UWWTD-Waterbase because its size was
below the reporting threshold of 2,000 p.e. National
consumption data and default WWTP characteristics might
thus not always suﬃce to estimate concentrations in locally
inﬂuenced rivers. The same likely holds for the tributaries of
the river Rhine sampled by Ruﬀ et al.42 (locations 11−16) and
by Munz et al.43 However, the pattern is less obvious here,
probably due to errors introduced by the aforementioned
incoherent ﬂow conditions, consumption data, and geo-
graphical detail on sampling locations and emission sources.
One option to improve predictions in upstream tributaries is to
extend the UWWTD-Waterbase with WWTPs smaller than
2000 p.e.
Figure 6A shows that predicted concentrations in the river
Ouse basin were highest for metformin, gabapentin and
acetaminophen, mainly resulting from their large consumption
volumes, high excretion fractions and/or relatively poor
degradation (SI S4.2 and S5). The prioritisation of APIs shifts
when based on potential risks to ﬁsh instead of concentrations
(Figure 6B). Metformin, gabapentin and acetaminophen drop
down the list and are replaced by other more pharmacolog-
ically active APIs. Desvenlafaxine, loratadine, and hydrocodone
(highlighted in Figure 6A) then become APIs of particular
interest. Their risk quotients for ﬁsh were larger than 0.1 in one
or more locations in the river basin, with risk quotients for
desvenlafaxine and loratadine even exceeding 1 in ∼26% and
∼10% of the river length, respectively. Interestingly,
desvenlafaxine is formed as a metabolite of its prodrug
venlafaxine but is not administered as a separate medication in
the United Kingdom. This provides a strong argument for
more focus on active metabolites in the environmental risk
assessment of pharmaceuticals. Finally, Figure 7 shows that
higher risks are mainly found in more densely populated areas,
for example, around the city of Leeds. The geographical
distribution of surface water concentrations and risk quotients
for all APIs is visualized in interactive html-maps in SI S7.
Our model evaluation showed that ePiE generally predicts
concentrations in surface waters within 1 order of magnitude
of measured concentrations for a wide range of pharmaceutical
classes. While other models have been shown to predict PECs
of APIs to within a factor 2−15 of measured concentrations,59
none of these models have been evaluated using such an
extensive data set on a diverse range of APIs. To further
strengthen conﬁdence in the model, future model development
and evaluation should extend toward additional, more
hydrologically and climatically diverse river basins. As part of
the IMI funded project iPiE, we are currently monitoring
additional river basins in Denmark, Germany, Spain, and the
UK to develop a broader data set against which to evaluate the
model. Because of its ﬂexible setup and the use of global high-
resolution gridded streamﬂow,22 ePiE can be extended to new
basins worldwide in a relatively straightforward way. Our
model results also showed that a proper assessment of model
performance requires measured concentrations derived under
the same conditions as those modeled. This means that further
model development should ideally be supported by long-term
annual sampling eﬀorts. In addition, incorporation of local
consumption patterns, point sources (e.g., hospitals and
pharmaceutical production plants), WWTP characteristics,
and environmental conditions, would be especially relevant for
adequate estimation of concentrations in smaller river
stretches.
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